Anavex Life Sciences Corp (AVXL)

[sokol]

In looking at a Demark chart and considering how this stock has moved over the years I have followed it, AVXL shares are likely to zigzag or wallow at this lower level for at least the next 6 trading days, which coincides with the CTAD as well. Of course if positive and convincing information is revealed at the CTAD, the stock should move up sharply. If the latter information is clearly negative, there will obviously be a sharper move down. In the meantime, I do not expect the stock to do much of anything. Lastly, based on my studies of this drug candidate, I am in the hopeful camp that we will get reliable and positive news, but I will manage my expectations waiting patiently to know more come the first part of November. I am actually writing this for myself to do just that … to help manage expectations and exercise patience.